People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Novus Therapeutics, Inc. | — | Biotechnology | Series D+ | $226.8M | $575.7M | 2024 |
| HYPR Corp. | — | Other Technology | Series B | $89.5M | $328.1M | 2019 |
| Netsertive, Inc. | — | Other Technology | Series B | $46.5M | $730.9M | 2010 |
| Chain, Inc. | — | Other Technology | Series B | $40.8M | $834.1M | 2015 |
| OpenSignal, Inc. | — | Other Technology | Series A | $9.1M | $253.0M | 2018 |
| Insurate, Inc. | — | Other | Series A | $4.5M | $47.2M | 2021 |
James Robinson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Robinson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Keith Rabois | 1 | 25 |
| Stuart Ellman | 1 | 18 |
| Eric Wiesen | 1 | 17 |
| Greg Dracon | 1 | 10 |
| Adam Ludwin | 1 | 10 |
| Wayne Hunter | 1 | 10 |
| Campbell Murray | 1 | 9 |
| Mark Jacobsen | 1 | 9 |
| Erez Chimovits | 1 | 7 |
| Timothy J. Barberich | 1 | 7 |
| John McBride | 1 | 7 |
| James D. Robinson IV | 1 | 7 |
| Bryan Smith | 1 | 6 |
| Adrian Jones | 1 | 6 |
| Kirill Sheynkman | 1 | 5 |
| Campbell A. Murray | 1 | 4 |
| Seth L. Harrison | 1 | 4 |
| Wayne L. Hunter | 1 | 3 |
| David Kessler | 1 | 3 |
| Reinhard J. Ambros | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.